Biopharmaceutical Companies

Juno Therapeutics Soars 25% After ROCKET Phase 2 Rocket Trial Resumption

Nexvet Biopharma Gains 15%, Company Reports Positive Results From Pilot Field Study

Here's Why OXiGENE Surged 65% Early Tuesday Morning

Nexvet Biopharma Gains 15%, Company Reports Positive Results From Pilot Field Study

Here's Why OXiGENE Surged 65% Early Tuesday Morning

Report: Medivation Committed To Selling Itself

Immunomedics Announces Encouraging Preclinical Study Data, Shares Give Up Early Morning Gains

Report: Medivation Committed To Selling Itself

Immunomedics Announces Encouraging Preclinical Study Data, Shares Give Up Early Morning Gains

PTC Therapeutics Spikes 40% After Translarna Update In England

Pain Therapeutics Gains 7%, FDA Has Accepted Company's Remoxy For Review